Characteristics of Immune Checkpoint Inhibitor (ICI)-Related Hepatotoxicity Based on the Baseline Liver Function
Cancer Research and Treatment · 2025
DOI: 10.4143/crt.2025.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Won-Jung Jung und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Korea. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Chemical and Drug Induced Liver Injury, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Korean Institute of Drug Safety and Risk Management, Pusan National University Hospital, Ministry of Health and Welfare.
Abstract (Originalsprache)
PURPOSE: This study estimated the incidence of immune checkpoint inhibitor-related hepatotoxicity (ICH), identified risk factors, and characterized patients who developed ICH. MATERIALS AND METHODS: Adult patients treated with immune checkpoint inhibitors (ICIs) from January 2015 to June 2022 in a tertiary hospital were included, excluding those without liver function tests or those with liver cancer but normal baseline liver function. Patients were stratified by baseline liver function status; in overall and each of stratified cohorts ICH incidence was calculated as the number of events per 100 person-years with grade 3 hepatotoxicity as the primary outcome. Patient characteristics were assessed using descriptive statistics, and risk factors were identified through multivariable Cox regression. Causality between ICI use and hepatotoxicity was assessed using the Naranjo Algorithm. RESULTS: Among 803 patients, the ICH incidence was 19.5 cases per 100 person-years, with a higher incidence (47.3 vs. 9.3 cases per 100 person-years) and earlier onset (13 vs. 15 days) in the abnormal compared to the normal group. Significant risk factors for ICH included female sex in the normal group and liver cancer in the abnormal group. According to the Naranjo Algorithm, all the 60 ICH cases were classified as "probable" or "possible". Among the 60 cases, 61.7% (n=37) resulted in ICI discontinuation. The baseline liver function did not impact on the severity or the likelihood of ICI discontinuation. CONCLUSION: Future studies are needed to evaluate whether the impact of ICI discontinuation on survival outcomes in patients with ICH varies based on baseline liver function abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Korea.
- Department of Internal Medicine, School of Medicine, Pusan National University, Busan, Korea.
- Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- College of Pharmacy and Department of Global Innovative Drugs, Chung-Ang University, Seoul, Korea.
- College of Pharmacy, Chung-Ang University, Seoul, Korea.
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Förderung
- Korean Institute of Drug Safety and Risk Management
- Pusan National University Hospital
- Ministry of Health and Welfare
- Korea Health Information Service
Zitieren
APA
Jung, W. J., Jo, E. J., Kim, Y. J., Park, M., Kim, E., Jung, Y. S., Park, S. R., Oh, J. S., Kim, S. H., Park, J., Jung, S. Y., & Jeon, N. (2025). Characteristics of Immune Checkpoint Inhibitor (ICI)-Related Hepatotoxicity Based on the Baseline Liver Function. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.040
Vancouver
Jung WJ, Jo EJ, Kim YJ, Park M, Kim E, Jung YS, et al. Characteristics of Immune Checkpoint Inhibitor (ICI)-Related Hepatotoxicity Based on the Baseline Liver Function. Cancer Research and Treatment. 2025. doi:10.4143/crt.2025.040
BibTeX
@article{Jung2025,
author = {Jung, Won-Jung and Jo, Eun-Jung and Kim, Ye-Jee and Park, Mihyun and Kim, Eunji and Jung, Yu-Seon and Park, Sook Ryun and Oh, Ji Seon and Kim, So-Hui and Park, Jeongbin and Jung, Sun-Young and Jeon, Nakyung},
title = {Characteristics of Immune Checkpoint Inhibitor (ICI)-Related Hepatotoxicity Based on the Baseline Liver Function},
journal = {Cancer Research and Treatment},
year = {2025},
doi = {10.4143/crt.2025.040}
}
EUVIMED